The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery
Article first published online: 9 AUG 2007
DOI: 10.1111/j.1365-2044.2007.05146.x
Additional Information
How to Cite
Cuthbertson, B. H., Card, G., Croal, B. L., McNeilly, J. and Hillis, G. S. (2007), The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery. Anaesthesia, 62: 875–881. doi: 10.1111/j.1365-2044.2007.05146.x
Publication History
- Issue published online: 9 AUG 2007
- Article first published online: 9 AUG 2007
- Accepted: 14 May 2007
Vol. 62, Issue 11, 1198, Article first published online: 8 OCT 2007
- Abstract
- Article
- References
- Cited By
Summary
B-type natriuretic peptide (BNP) levels predict cardiovascular risk in several settings. We hypothesised that they would identify individuals at increased risk of complications and mortality following major emergency non-cardiac surgery. Forty patients were studied with a primary end-point of a new postoperative cardiac event, and/or development of significant ECG changes, and/or cardiac death. The main secondary outcome was all-cause mortality at 6 months. Pre-operative BNP levels were higher in 11 patients who suffered a new postoperative cardiac event (p = 0.001) and predicted this outcome with an area under the receiver operating characteristic curve of 0.85 (CI = 0.72–0.98, p = 0.001). A pre-operative BNP value > 170 pg.ml−1 has a sensitivity of 82% and a specificity of 79% for the primary end-point. In this small study, pre-operative BNP levels identify patients undergoing major emergency non-cardiac surgery who are at increased risk of early postoperative cardiac events. Larger studies are required to confirm these data.

1365-2044/asset/olbannerleft.gif?v=1&s=bd83df57543a1d11ffc15f630bb1301f0be80859)
1365-2044/asset/olbannerright.gif?v=1&s=682381a959ba60d2021adaffc90d459e71bfcaba)
